Inogen Inc.

INGN | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.13

+$0.03 (+0.59%)

Sep 22, 2026, 2:45 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.59%

(1D)

Rating

Updated: Sep 11, 2026

28.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $139.03M

1D Range

5.11 5.20

52W Range

5.06 9.13

Valuation (TTM)

PE -5.67

PB 0.79

EV/EBITDA -4.30

Valuation (NTM)

Forward PE N/A

Forward PEG 0.15

Price Target $26

Cash Flow

FCF Yield -5.1%

SBC Adj. FCF Yield -10.3%

SBC Impact -104.4%

Margins

Gross Margin 48.9%

Operating Margin -8.4%

FCF Margin -2.0%

Growth (CAGR)

Revenue 3Y | 5Y 0.5% | 1.0%

Dil EPS 3Y | 5Y 77.7% | 16.8%

FCF 3Y | 5Y 38.9% | 29.7%

Returns

ROA -8.6%

ROE -13.2%

ROIC -13.3%

Financial Health

Net Cash

$89.75M

Current Ratio 2.74

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide cont...

Sector Healthcare

Industry Medical - Devices

Employees 753

IPO Date Feb 13, 2014

Website www.inogen.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞